Abstract
Animal studies and human case reports show promise in using lipid rescue to treat refractory calcium channel antagonist toxicity. However, the majority of research and clinical experience has focused on non-dihydropyridine agents. Thus, we sought to investigate the value of lipid emulsion (ILE) therapy for dihydropyridine-induced shock. This IACUC-approved study utilized seven swine that were sedated with alpha-chloralose, mechanically ventilated, and instrumented for drug delivery and hemodynamic measures. After stabilization and basal measures, nifedipine (0.01875 mg/kg/min) was infused until imminent cardiac arrest (seizure, end tidal CO2 < 10 mmHg, bradydysrhythmia, or pulseless electrical activity). Animals then received a 7 mL/kg bolus of 20% lipid emulsion via central catheter. Lipid circulation was visually confirmed by the presence of fat in peripheral arterial blood. Hemodynamics were continuously monitored until 10 min after lipid bolus. Surviving animals were euthanized. Pre- and post-lipid treatment parameters were analyzed using the Wilxocon signed rank test (p <0.05 significant). Nifedipine toxicity was characterized by vasodilatory hypotension, impaired vascular contractility, and tachycardia with terminal bradycardia. The median time to imminent cardiac arrest from start of nifedipine infusion was 218 min. Lipid treatment did not improve hemodynamics or restore circulation in any animal. There was no benefit from lipid rescue in this model of nifedipine toxicity. Further study of ILE for dihydropyridine toxicity is warranted but initial animal model results are not promising.
Similar content being viewed by others
References
Ozcan MS, Weinberg G. Intravenous lipid emulsion for the treatment of drug toxicity. J Intensive Care Med. 2014;29:59–70.
Huang JM-C, Xian H, Bacaner M. Long chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89:6452–6.
Mowry J, Spyker DA, Cantilena LR, McMillan N, Ford M. . (2013) annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol. 2014;52:1032–283.
Tebbutt S, Harvey M, Nicholson T, Cave G. Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med. 2006;13:134–9.
Bania TC, Chu J, Perez E, Su M, Hahn I. Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline. Acad Emerg Med. 2007;14:105–11.
Perez E, Bania TC, Medlej K, Chu J. Determining the optimal dose of intravenous fat emulsion for the treatment of severe verapamil toxicity in a rodent model. Acad Emerg Med. 2008;15:1284–9.
Geib AJ, Liebelt E. Manini AF on behalf of the toxicology investigators’ consortium (ToxIC). Clinical experience with intravenous lipid emulsion for drug-induced cardiovascular collapse. J Med Toxicol. 2012;8:10–4.
Young AC, Velez LI, Kleinschmidt. Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose. Resuscitation. 2009;80:591–3.
Dolcourt B, Aaron C. Intravenous fat emulsion for refractory verapamil and atenolol induced-shock: a human case report. Clin Toxicol. 2008;42:620.
Franxman TJ, Al-Nabhan M, Cavallazzi RS, Speak AJ. Lipid emulsion therapy for verapamil overdose. Ann Intern Med. 2011;154:292.
French D, Armenian P, Ruan W, Wong A, Drasner K, Olson K, AHB W. Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose. Clin Toxicol. 2011;49:340–4.
Levine M, Skolnik AB, Ruha AM, Bosak A, Menke N, Pizon AF. Complications following antidotal use of intravenous lipid emulsion therapy. J Med Toxicol. 2014;10:10–4.
Montiel V, Gougnard T, Hantson P. Diltiazem poisoning treated with hyperinsulinemic euglycemia therapy and intravenous lipid emulsion. Eur J Emerg Med. 2011;18:121–3.
Bologa C, Lionte C, Coman A, Sorodoc L. Lipid emulsion therapy in cardiodepressive syndrome after diltiazem overdose—case report. Am J Emerg Med. 2013;31:1154.
Stellpflug SJ, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Cardiotoxic overdose treated with intravenous fat emulsion and high-dose insulin in the setting of hypertrophic cardiomyopathy. J Med Toxicol. 2011;7:151–3.
Weinberg RL, Bouchard NC, Abrams DC, Bachetta M, Dzierba AL, Burkart KM, Brodie D. Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose. Perfusion. 2014;29:53–6.
Chu J, Medlej K, Bania T, Perez E, Mouravev R. The effect of intravenous fat emulsions in nifedipine toxicity. Acad Emerg Med. 2009;16:s226.
Cevik SE, Tasyurek T, Guneysel O. Intralipid emulsion treatment as an antidote in lipophilic drug intoxications. Am J Emerg Med. 2014;32:1103–8.
West PL, McKeown, Hendrickson RG. Iatrogenic lipid emulsion overdose in a case of amlodipine poisoning. Clin Toxicol. 2010;48:393–6.
Bebarta VS, Tanen DA, Boudreau S, Castaneda M, Zarzabal LA, Vargas T, et al. Intravenous cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model. Ann Emerg Med. 2014;64(6):612–9.
Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol. 2010;48:806–12.
Varney SM, Bebarta VS, Vargas TE, Boudreau S, Castaneda M. Intravenous lipid emulsion therapy does not improve hypotension when compared to sodium bicarbonate for tricyclic antidepressant toxicity: a randomized, controlled pilot study in a swine model. Acad Emerg Med. 2014;21(11):1212–9.
Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. 2007;45:396–401.
Liang CW, Diamond SJ, Hagg DS. Lipid rescue of massive verapamil overdose. J Med Case Rep. 2011;5:399.
Holzgrefe HH, Everitt JM, Wright EM. Alpha-chloralose as a canine anesthetic. Lab Animal. 1987;37:587–95.
Kerns W, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute β-blocker toxicity. Ann Emerg Med. 1997;29:748–57.
Kline JA, Tomaszewski CA, Schroeder JD v, Raymond RM. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine. J Pharmacol Exp Ther. 1993;267:744–50.
White N, Martin E, Brophy D, Ward K. Coagulation and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation. Resuscitation. 2010;81:111–6.
Leong B, Reynolds P, Tiba M, et al. Effects of a combination hemoglobin based oxygen carrier-hypertonic saline solution on oxygen transport in the treatment of traumatic shock. Resuscitation. 2011;82:937–43.
Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion recues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28:198–202.
Harvey M, Cave G. Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity. Ann Emerg Med. 2007;49:178–85.
Szebeni J, Alving CR, Rosivall L, Bunger R, Baranyi L, Bedocs P, Toth M, Baraenholz Y. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res. 2007;17:107–17.
Szebeni J, Fontana JL, Wassef NM, Mongan PD, Morse DS, Dobbins DE, Stahl GL, Bunger R, Alving CR. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs. A model for pseudoallergic cardiopulmonary reactions to liposomes: role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation. 1999;99:2302–9.
Wassef NM, Johnson SH, Graeber GM, Swartz GM, Schultz CJ, Hailey JR, Johnson AJ, Taylor DG, Ridgway RL, Alving CR. Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs. J Immunol. 1989;143:2990–5.
Acknowledgments
The investigators wish to thank Kristin Engebretsen, PharmD, for her assistance with nifedipine preparation and dosing and David McLaughlin and Edwards Lifesciences for the in-kind donation of the Edwards Lifesciences EV1000®.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
Funding for this research was provided by the Carolinas Healthcare Foundation and the John A. Marx, MD Fund.
Conflicts of Interest
The authors have no conflicts of interest to disclose.
Additional information
Previous Presentation: An abstract of this study was presented as a poster and as a platform at the American College of Medical Toxicology 2013 Annual Scientific Meeting (Murphy CM, Williams C, Quinn ME, Nicholson B, Shoe T, Beuhler MC, Kerns WP. Pilot trial of lipid rescue in a swine model of severe nifedipine toxicity. J Med Toxicol. 2013;9:82).
Rights and permissions
About this article
Cite this article
Murphy, C.M., Williams, C., Quinn, M.E. et al. Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock. J. Med. Toxicol. 12, 380–385 (2016). https://doi.org/10.1007/s13181-016-0572-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-016-0572-6